妊娠创伤患者胎儿分娩的预测因素:一项多中心研究
这项多中心回顾性研究纳入2016—2021年12家一级和二级创伤中心的591例妊娠≥24周妊娠创伤患者,比较住院期间发生胎儿分娩者(63例,10.7%)与未分娩者的特征。胎儿分娩组孕周更大(37 vs 30周,p<0.001)、损伤严重度评分更高(7.0 vs 1.5,p<0.001),阴道出血(6.3% vs 1.1%,p=0.002)、宫缩(46% vs 23.5%,p<0.001)和胎心监护异常(54.7% vs 14.6%,p<0.001)比例更高。多因素分析显示腹部损伤(OR 4.07)、孕周(每增加1周OR 1.68)、胎心监护异常(OR 12.72)和胎膜早破(OR 35.97)是胎儿分娩的独立预测因素。作者认为这些因素多可在创伤抢救室初始评估中获得,有助于预测胎儿分娩并指导未来观察指南的制定。
要点
- 妊娠≥24周创伤患者胎儿分娩率约10.7%(63/591),其中4例(6.3%)孕产妇死亡。
- 多因素独立预测因素:腹部损伤OR 4.07(95%CI 1.11-15.02,p=0.035)、孕周每增加1周OR 1.68(95%CI 1.44-1.95,p<0.001)。
- 胎心监护异常OR 12.72(95%CI 5.19-31.17,p<0.001)、胎膜早破OR 35.97(95%CI 7.28-177.74,p<0.001)是胎儿分娩的强预测因素。
- 胎儿分娩组孕周更大(37 vs 30周,p<0.001)、损伤严重度评分更高(7.0 vs 1.5,p<0.001),阴道出血(6.3% vs 1.1%,p=0.002)和宫缩(46% vs 23.5%,p<0.001)更多见。
- 这些预测因素多数可在创伤抢救室初始评估中获得,作者认为可能有助于预测胎儿分娩并指导未来观察指南的制定。
适用人群与场景
- 年龄≥18岁、妊娠≥24周的妊娠创伤患者,来自2016—2021年12家一级和二级创伤中心。
- 比较住院期间发生胎儿分娩者与未分娩者。
诊断标准与关键阈值
- 胎儿分娩定义为指数住院期间发生分娩。
- 孕周≥24周为纳入界值;多因素模型中孕周按每增加1周计算(OR 1.68,95%CI 1.44-1.95,p<0.001)。
红旗征与不能漏的情况
- 胎心监护异常:胎儿分娩组54.7% vs 未分娩组14.6%(p<0.001),多因素OR 12.72(95%CI 5.19-31.17,p<0.001)。
- 胎膜早破:多因素OR 35.97(95%CI 7.28-177.74,p<0.001)。
- 阴道出血:胎儿分娩组6.3% vs 未分娩组1.1%(p=0.002)。
- 子宫收缩:胎儿分娩组46% vs 未分娩组23.5%(p<0.001)。
研究设计与关键结果
- 多中心回顾性研究,纳入591例妊娠≥24周的妊娠创伤患者,63例(10.7%)发生胎儿分娩,其中4例(6.3%)孕产妇死亡。
- 胎儿分娩组与未分娩组母亲年龄相似(27 vs 28岁,p=0.310),但孕周更大(37 vs 30周,p<0.001)、损伤严重度评分更高(7.0 vs 1.5,p<0.001)。
- 胎儿分娩组阴道出血(6.3% vs 1.1%,p=0.002)、子宫收缩(46% vs 23.5%,p<0.001)、胎心监护异常(54.7% vs 14.6%,p<0.001)比例更高。
- 多因素分析独立预测因素:腹部损伤OR 4.07(95%CI 1.11-15.02,p=0.035);孕周每增加1周OR 1.68(95%CI 1.44-1.95,p<0.001);胎心监护异常OR 12.72(95%CI 5.19-31.17,p<0.001);胎膜早破OR 35.97(95%CI 7.28-177.74,p<0.001)。
证据类型、等级与局限
- 证据类型:多中心回顾性研究;证据等级:治疗/照护管理,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对妊娠≥24周创伤患者,初始创伤抢救室评估中应关注腹部损伤、孕周、胎心监护异常和胎膜早破,这些因素与胎儿分娩风险独立相关。
- 作者认为这些风险因素可能有助于预测创伤场景下的胎儿分娩,并指导未来关于妊娠创伤患者推荐观察的指南制定。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pregnant trauma patients (PTPs) undergo observation and fetal monitoring following trauma due to possible fetal delivery (FD) or adverse outcome. There is a paucity of data on PTP outcomes, especially related to risk factors for FD. We aimed to identify predictors of posttraumatic FD in potentially viable pregnancies.
METHODS: All PTPs (≥18 years) with ≥24-weeks gestational age were included in this multicenter retrospective study at 12 Level-I and II trauma centers between 2016 and 2021. Pregnant trauma patients who underwent FD ((+) FD) were compared to those who did not deliver ((-) FD) during the index hospitalization. Univariate analyses and multivariable logistic regression were performed to identify predictors of FD.
RESULTS: Of 591 PTPs, 63 (10.7%) underwent FD, with 4 (6.3%) maternal deaths. The (+) FD group was similar in maternal age (27 vs. 28 years, p = 0.310) but had older gestational age (37 vs. 30 weeks, p < 0.001) and higher mean injury severity score (7.0 vs. 1.5, p < 0.001) compared with the (-) FD group. The (+) FD group had higher rates of vaginal bleeding (6.3% vs. 1.1%, p = 0.002), uterine contractions (46% vs. 23.5%, p < 0.001), and abnormal fetal heart tracing (54.7% vs. 14.6%, p < 0.001). On multivariate analysis, independent predictors for (+) FD included abdominal injury (odds ratio [OR], 4.07; confidence interval [CI], 1.11-15.02; p = 0.035), gestational age (OR, 1.68 per week ≥24 weeks; CI, 1.44-1.95; p < 0.001), abnormal FHT (OR, 12.72; CI, 5.19-31.17; p < 0.001), and premature rupture of membranes (OR, 35.97; CI, 7.28-177.74; p < 0.001).
CONCLUSION: The FD rate was approximately 10% for PTPs with viable fetal gestational age. Independent risk factors for (+) FD included maternal and fetal factors, many of which are available on initial trauma bay evaluation. These risk factors may help predict FD in the trauma setting and shape future guidelines regarding the recommended observation of PTPs.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Santos JW, Grigorian A, Lucas AN, et al. Predictors of fetal delivery in pregnant trauma patients: A multicenter study. J Trauma Acute Care Surg. 2023. PMID: 37580875. doi:10.1097/TA.0000000000003964
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。